Technical Analysis for PBE - PowerShares Dynamic Biotech & Genome
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 64.06 | 0.78% | 0.49 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 50 DMA | Bullish | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| 50 DMA Resistance | Bearish | 0.78% | |
| Gapped Up | Strength | 0.78% | |
| Crossed Above 20 DMA | Bullish | 1.91% | |
| Crossed Above 200 DMA | Bullish | 1.91% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 3 days ago |
| Gapped Up (Full) | 3 days ago |
| Rose Above Previous Day's High | 3 days ago |
| Rose Above Upper Bollinger Band | 3 days ago |
| Rose Above 50 DMA | 3 days ago |
Get a Trading Sidekick!
PowerShares Dynamic Biotech & Genome Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Classification
Keywords: Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Invesco Powershares Genetic Engineering Inter 10 Index Genome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 67.6644 |
| 52 Week Low | 52.4502 |
| Average Volume | 17,493 |
| 200-Day Moving Average | 61.39 |
| 50-Day Moving Average | 63.66 |
| 20-Day Moving Average | 61.51 |
| 10-Day Moving Average | 61.55 |
| Average True Range | 1.03 |
| RSI (14) | 60.47 |
| ADX | 25.17 |
| +DI | 41.49 |
| -DI | 26.48 |
| Chandelier Exit (Long, 3 ATRs) | 61.81 |
| Chandelier Exit (Short, 3 ATRs) | 62.40 |
| Upper Bollinger Bands | 64.21 |
| Lower Bollinger Band | 58.81 |
| Percent B (%b) | 0.97 |
| BandWidth | 8.77 |
| MACD Line | -0.22 |
| MACD Signal Line | -0.72 |
| MACD Histogram | 0.4973 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 65.31 | ||||
| Resistance 3 (R3) | 65.44 | 65.17 | 65.10 | ||
| Resistance 2 (R2) | 65.17 | 64.85 | 65.10 | 65.03 | |
| Resistance 1 (R1) | 64.61 | 64.65 | 64.47 | 64.47 | 64.96 |
| Pivot Point | 64.34 | 64.34 | 64.27 | 64.27 | 64.34 |
| Support 1 (S1) | 63.78 | 64.02 | 63.64 | 63.64 | 63.16 |
| Support 2 (S2) | 63.50 | 63.82 | 63.44 | 63.09 | |
| Support 3 (S3) | 62.95 | 63.50 | 63.02 | ||
| Support 4 (S4) | 62.81 |
